Kava, a rising herbal remedy, shows promise as a treatment for anxiety and insomnia, with 63% of users reporting improved relaxation and mood. Despite its increasing popularity in the U.S., where it is marketed as a safe dietary supplement, concerns about product quality and variability persist. Healthcare professionals must understand kava's potential effects and interactions due to inconsistent findings in studies. Familiarity with its pharmacology is essential for effectively managing kava use in patients seeking natural alternatives for psychological relief.
Ayahuasca is a traditional Amazonian hallucinogenic brew that has been used for centuries in shamanic ceremonies and is gaining popularity in the United States for its spiritual and psychotherapeutic benefits. The decoction combines a monoamine oxidase inhibitor from Banisteriopsis caapi with a serotonergic 2A receptor agonist from Psychotria viridis or Diplopterys cabrerana. Potential risks include psychotic episodes related to N,N-dimethyltryptamine and potentially life-threatening serotonin syndrome. Consequences of use remain uncertain due to poor quality control, unpredictability, and polydrug interactions. Healthcare providers need familiarity with its pharmacology, drug interactions, and management for optimal decision making.